Kyverna Therapeutics, Inc. — Investor Relations & Filings
Kyverna Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing cell therapies for patients with autoimmune diseases. The company's approach involves engineering a patient's own T cells into Chimeric Antigen Receptor (CAR) T-cells to target and deplete B cells, which are central to the pathology of many autoimmune disorders. By adapting a technology proven in oncology, Kyverna aims to reset the immune system and achieve a durable, treatment-free remission from a single infusion. Its lead product candidate, KYV-101, is an autologous, fully human anti-CD19 CAR T-cell therapy being investigated in clinical trials for conditions including lupus nephritis and multiple sclerosis.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - Kyverna Therapeutics, Inc. (0001994702) (Filer) | 2026-05-04 | English | |
| 8-K - Kyverna Therapeutics, Inc. (0001994702) (Filer) | 2026-04-22 | English | |
| 8-K - Kyverna Therapeutics, Inc. (0001994702) (Filer) | 2026-04-20 | English | |
| ARS - Kyverna Therapeutics, Inc. (0001994702) (Filer) | 2026-04-13 | English | |
| DEF 14A - Kyverna Therapeutics, Inc. (0001994702) (Filer) | 2026-04-13 | English | |
| 424B5 - Kyverna Therapeutics, Inc. (0001994702) (Filer) | 2026-04-02 | English |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Kyverna Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33477/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33477 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33477 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33477 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33477}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Kyverna Therapeutics, Inc. (id: 33477)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.